Dr. Jun Liang 梁军
Chief Physician
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for thoracic tumors, including lung cancer, esophageal cancer, thymic cancer, and tracheal cancer. Focuses on concurrent chemoradiotherapy, intensity-modulated radiation therapy, image-guided radiation therapy, and management of radiotherapy complications.
Dr. Liang graduated from Hunan Medical University in 1992 and has worked in the Department of Radiation Oncology at Cancer Hospital, Chinese Academy of Medical Sciences since then. Promoted to Associate Chief Physician in 2005. Served as a visiting physician at Kiang Wu Hospital Radiation Therapy Center in Macau from July 2004 to December 2005. Has published several papers as first author in domestic core journals.
Name order: in Chinese the family name comes first (Liang Jun). Papers usually list the name as Jun Liang or Liang J.
Selected publications
38 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Nutr, 2025 (senior author): Nutritional management for a lung cancer patient receiving concurrent radiotherapy and immunotherapy and developing immune-related dermatitis: a case report. PubMed 41334332
- Front Immunol, 2025 (senior author): Case Report: The huge esophageal displacement: a case of dramatic esophageal interfraction motion during neoadjuvant chemotherapy and immunotherapy. PubMed 40777018
- Pain Manag Nurs, 2025 (senior author): Efficacy of Multidisciplinary Pain Management for Advanced Cancer Patients. PubMed 39924397
- Med Dosim, 2025 (senior author): Dosimetric superiority of deep inspiration breath hold-proton beam therapy for cardiac metastasis. PubMed 40157883
- Front Immunol, 2023 (senior author): Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review. PubMed 37101827
- Front Immunol, 2022 (senior author): Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review. PubMed 36439117
- Chin Med J (Engl), 2022 (senior author): Percutaneous local tumor ablation vs . stereotactic body radiotherapy for early-stage non-small cell lung cancer: a systematic review and meta-analysis. PubMed 35830244
- Medicine (Baltimore), 2021 (senior author): Image-guided, intensity-modulated radiotherapy for the treatment of diffuse-type tenosynovial giant cell tumor of the knee: Case report and review of the literature. PubMed 34260572
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion